This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Siemens Healthineers company Varian will distribute Mirion Technologies subsidiary Sun Nuclear's SunCheck quality management software for radiation therapy departments. The deal will help Varian expand its quality assurance and interoperability offerings, it said. SunCheck will continue to be available from Sun Nuclear itself and its other distributors.
In a series of enlightening conversations with Avi Sharma, MD CIIP, Director of AI at Jefferson Einstein Hospitals, we gained valuable insights into his experience as an early adopter of AI in radiology and the trajectory of its development. Dr. Sharma shared his expertise on creating an initial AI strategy, fostering continuous education and the role of opportunistic screening and AI care coordination.
The COVID-19 pandemic exposed flaws in the global supply chain. Most American manufacturers, retailers, and consumers thought they could access products easily. Then, they learned they had considerably less control than they had imagined. Although supply chains have largely recovered from pandemic woes, climate change, geopolitical strife, and other issues still disrupt plans.
The IND application allows researchers to test investigational drugs in humans, ensuring safety and regulatory compliance throughout development. The post Understanding the Investigational New Drug (IND) Application appeared first on Open MedScience.
Amidst rising cancer prevalence and soaring costs, new cancer technologies and innovations are emerging to support the early detection, treatment, and surveillance of cancer. Read this guide to understand how to evaluate these solutions for your employees and members – and to learn more about the current state of coverage, clinical and cost effectiveness, and impact on quality and outcomes.
Acute calculus cholecystitis affects approximately 10%–20% of individuals with symptomatic gallstones, often necessitating laparoscopic or robotic cholecystectomy as the gold standard. Although effective, this procedure carries risks of bile leak, biliary stricture, retained common bile duct stones, and dropped gallstones (DGs). Approximately 6%–7% of laparoscopic cholecystectomy cases result in DGs, with about 8.5% of these cases becoming symptomatic (1,2).
This article explores cancer treatment advancements, tumour biology complexities, and the critical role of palliative care in oncology. The post Advances in Oncology: Cancer Treatment, Tumour Biology, and Palliative Care appeared first on Open MedScience.
40
40
Sign up to get articles personalized to your interests!
Diagnostic Imaging Brief brings together the best content for architecture professionals from the widest variety of industry thought leaders.
This article explores cancer treatment advancements, tumour biology complexities, and the critical role of palliative care in oncology. The post Advances in Oncology: Cancer Treatment, Tumour Biology, and Palliative Care appeared first on Open MedScience.
Since it was first described in 1990, flap fenestration has been performed to treat malperfusion resulting from complicated aortic dissection (1). Malperfusion is a life-threatening complication present in approximately 20% of descending aortic dissections and greatly increases mortality (2). Malperfusion results from compromise of branch vessels, either primarily involved by dissection or secondarily involved from collapse of the aortic true lumen.
Publication date: Available online 28 September 2024 Source: Clinical Radiology Author(s): Michael Frenkel, Siddhanth Iyer, Ryan Antar, Amman Akram, Sean M.
Primary splenic angiosarcoma is rare, with less than 300 cases reported and an incidence rate of 0.14–0.23 cases per 1 million (1). No randomized trials are available to guide treatment, which typically includes the combination of splenectomy, chemotherapy, and radiotherapy (1). This report describes long-term disease control of a primary splenic angiosarcoma with yttrium-90 (90Y) radioembolization complicated by radiation gastritis and gastric hemorrhage 3 years after treatment.
Advancements in medical science have dramatically improved healthcare outcomes, extending life expectancy and enhancing overall quality of life. The post The Evolution of Medicine: A Historical Journey from Ancient Times to Modern Advances appeared first on Open MedScience.
Patient-centric scheduling can only be achieved through optimized radiology workflows, effective communications between staff and physicians, and, of course, through specialized schedulers. In this guide, we’ll take you through a step-by-step process to transform your radiology center into a high-performance hub of medical imaging.
The study purpose was to evaluate Denali IVC filter (Bard Peripheral Vascular, Tempe, Arizona) outcomes. Five hundred patients had 508 filters placed between 2015 and 2022. Filters were retrieved at the study site in 284 patients, 159 (31.4%) were deemed permanent, 21 (4.1%) were retrieved at an outside hospital, 27 (5.3%) had outside hospital follow-up without known retrieval, and 17 (3.3%) were lost to follow-up.
Product knowledge enables Medical Science Liaisons to accurately convey drug mechanisms, clinical trial data, safety, and efficacy profiles. The post The Role of Medical Science Liaisons in Product Knowledge appeared first on Open MedScience.
We organize all of the trending information in your field so you don't have to. Join 5,000 users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content